PALATIN TECHNOLOGIES, INC. Allowance for Loan and Lease Losses, Loans Acquired
PALATIN TECHNOLOGIES, INC. (PTN) reported Allowance for Loan and Lease Losses, Loans Acquired of $7.59 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Notes › Credit Losses
us-gaap:AllowanceForLoanAndLeaseLossesLoansAcquired · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. allowance for loan and lease losses, loans acquired for fiscal 2025 was $7.59M, a 32.18% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. allowance for loan and lease losses, loans acquired for fiscal 2024 was $11.19M, a 98.00% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. allowance for loan and lease losses, loans acquired for fiscal 2023 was $5.65M, a 43.95% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. allowance for loan and lease losses, loans acquired for fiscal 2022 was $3.93M.
| Period end | Allowance for Loan and Lease Losses, Loans Acquired 1 month | Allowance for Loan and Lease Losses, Loans Acquired 12 month |
|---|---|---|
| 2025-06-30 | $7.59M 10-K · filed 2025-09-23 | |
| 2024-06-30 | $11.19M 10-K · filed 2025-09-23 | |
| 2023-06-30 | $5.65M 10-K · filed 2024-09-30 | |
| 2022-06-30 | $3.93M 10-K · filed 2023-09-28 | |
| 2021-06-30 | $9.51M 10-K · filed 2022-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |